Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
Australia
/
Healthcare
Create a narrative
Nova Eye Medical Community
ASX:EYE Community
1
Narratives
written by author
0
Comments
on narratives written by author
12
Fair Values set
on narratives written by author
Create a narrative
Nova Eye Medical
Popular
Undervalued
Overvalued
Community Investing Ideas
Nova Eye Medical
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
US And European Market Expansion Will Unlock New Opportunities
Key Takeaways Record sales growth in the U.S. and strategic geographic expansion are driving revenue and market share growth, especially in the Glaucoma division. Strategic opportunities in drug delivery and improved operating leverage are anticipated to enhance long-term growth and profitability.
View narrative
AU$0.41
FV
69.9% undervalued
intrinsic discount
32.83%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
9
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
EYE
EYE
Nova Eye Medical
Your Fair Value
AU$
Current Price
AU$0.13
81.6% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-14m
95m
2015
2018
2021
2024
2025
2027
2030
Revenue AU$94.9m
Earnings AU$13.8m
Advanced
Set Fair Value